Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -252.07% | -201.39% | -117.96% | -71.60% | 70.31% |
| Total Depreciation and Amortization | -74.57% | -75.86% | -54.68% | -33.01% | -17.11% |
| Total Amortization of Deferred Charges | -3.38% | -9.30% | -15.92% | -23.05% | -18.07% |
| Total Other Non-Cash Items | 231.67% | 28.51% | -43.64% | -83.05% | -80.88% |
| Change in Net Operating Assets | -116.56% | -134.54% | -134.41% | -145.70% | 387.79% |
| Cash from Operations | -1,968.97% | -4,838.47% | -11,128.42% | -3,884.99% | 105.75% |
| Capital Expenditure | -103.85% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,765.93% | 439.01% | 454.00% | 171.29% | 81.80% |
| Cash from Investing | 1,761.33% | 438.74% | 453.79% | 171.23% | 81.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 16.66% |
| Issuance of Common Stock | 719.49% | 921.46% | 292.69% | -99.56% | -99.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -100.00% | -- |
| Cash from Financing | 176.32% | 155.93% | 117.16% | -99.52% | -104.43% |
| Foreign Exchange rate Adjustments | -200.00% | 238.24% | -93.52% | 1,653.85% | 370.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 222.00% | -159.74% | 63.93% | -221.44% | 62.69% |